TRANDATE 5 mg/ml, solution for injection 5 ampoules of 20 ml
Active ingredients: Labetalol hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for injection5 ampoules of 20 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TRANDATE 5 mg/ml, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 5 ampoule(s) de 20 ml
- Marketing authorisation holder
- ASPEN PHARMA TRADING (IRLANDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Apr 1982
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60558554CIP75524943CIP133400955249436Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LABÉTALOL (CHLORHYDRATE DE)solution | 100 mg · une ampoule de 20 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.